Immunogen (IMGN)

5.18 -0.21 (3.90%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (2/11/19 *Est.)

Latest Headlines

ImmunoGen Presents New Data Highlighting Potential of Novel ADCs in Oral Presentations at ASH Annual Meeting December 1, 2018 10:31 AM - BizWire Form 8-K IMMUNOGEN INC For: Nov 26 November 26, 2018 4:16 PM - SEC Filing Immunogen (IMGN) Reports Resignation of CFO November 26, 2018 4:02 PM - StreetInsider ImmunoGen Announces Resignation of Chief Financial Officer November 26, 2018 4:01 PM - BizWire Immunogen (IMGN) Director Goldberg Buys 30K Shares November 7, 2018 9:58 AM - StreetInsider Form 4 IMMUNOGEN INC For: Nov 06 Filed by: Goldberg Mark Alan November 7, 2018 9:54 AM - SEC Filing Report: Developing Opportunities within TE Connectivity, EnPro Industries, Innophos, Ameren, ImmunoGen, and ICF International — Future Expectations, Projections Moving into 2018 November 7, 2018 8:20 AM - Globe NewsWire ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences November 6, 2018 4:30 PM - BizWire Form 10-Q IMMUNOGEN INC For: Sep 30 November 2, 2018 11:46 AM - SEC Filing Form 8-K IMMUNOGEN INC For: Nov 02 November 2, 2018 6:36 AM - SEC Filing Immunogen (IMGN) Reports In-Line Q3 EPS, Revenues Miss; Offers FY18 Revenue Outlook Below Consensus November 2, 2018 6:36 AM - StreetInsider ImmunoGen Reports Recent Progress and Third Quarter 2018 Operating Results November 2, 2018 6:30 AM - BizWire ImmunoGen to Present New Data on Novel Antibody-Drug Conjugates at 60th ASH Annual Meeting November 1, 2018 9:01 AM - BizWire Immunogen (IMGN) Highlights Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA October 22, 2018 6:07 AM - StreetInsider ImmunoGen Presents Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO 2018 Congress October 20, 2018 6:30 AM - BizWire ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2018 Operating Results October 18, 2018 4:30 PM - BizWire Form 4 IMMUNOGEN INC For: Oct 16 Filed by: Berkenblit Anna October 17, 2018 9:52 AM - SEC Filing Report: Developing Opportunities within Southwest Airlines, Select Income REIT, Oxford Industries, ImmunoGen, Navigant Consulting, and TrueBlue — Future Expectations, Projections Moving into 2018 October 10, 2018 8:30 AM - Globe NewsWire ImmunoGen to Present Initial Data from FORWARD II Expansion Cohort of Mirvetuximab Soravtansine in Combination with KEYTRUDA at ESMO October 8, 2018 6:05 PM - BizWire Form 4 IMMUNOGEN INC For: Sep 30 Filed by: MITCHELL DEAN J October 1, 2018 3:16 PM - SEC Filing Form 4 IMMUNOGEN INC For: Sep 30 Filed by: Goldberg Mark Alan October 1, 2018 3:15 PM - SEC Filing Form CT ORDER IMMUNOGEN INC September 25, 2018 2:44 PM - SEC Filing ImmunoGen Announces Webcasts of Presentations at Upcoming Conferences September 24, 2018 4:30 PM - BizWire Form 3 IMMUNOGEN INC For: Sep 13 Filed by: FOSTER DAVID G September 20, 2018 4:28 PM - SEC Filing Guggenheim Starts Immunogen Inc. (IMGN) at Buy September 17, 2018 4:29 PM - StreetInsider Full Article List